Don't Jump to Spiriva First-Line for Mild COPD
New evidence will spark controversy over how to treat COPD patients with MILD disease.
About seven in 10 COPD patients have early disease with minimal symptoms. But meds are usually studied in moderate to severe COPD.
Now evidence suggests that Spiriva (tiotropium), a long-acting muscarinic antagonist (LAMA), may be beneficial for mild COPD.